1. 1 Ideas ASA The Medical Technology Company

2. 2 The Medical Diagnostic Imaging and Monitoring Market A USD 90 billion market divided into : Functional Imaging (Nuclear Medicine)  SPECT  PET X-Ray (including Computed Tomography - CT) Ultra Sound Magnetic Resonance (MR) Target Market Ideas core market

3. 3 Ideas Vision and Mission Vision To become the world’s leading supplier of Detection Modules for Functional Imaging. Mission To improve patient care and save lives through delivery of improved and more efficient imaging detection capabilities that can detect cancer and diagnose diseases earlier with use of less radiation.

4. 4 Established in 1992 based on research at Cern (Switzerland) 10 Technology Patents 27 employees from 7 countries Hereof 6 with Ph.D Experienced management team Company Background

5. 5 How is this possible ? Extremely talented people with world wide reputation Innovative and unique patented technology Slim and small detectors allow dedicated cameras (analogy to flat screen PC vs table PC) * x * Anger Camera New technology Nuclear Medicine Computer Tomograph (SPECT - Old technology) Ideas recognized as the best vendor to this level * * (References GE, Philips, Siemens, as well as Glenn Knoll)

6. 6 Ideas Market Potential Functional Imaging ApplicationProduct Tot. US Market (Card.centers) # syst. Per year Sales price from Ideas ($/CH) Annual market pot. 2002 (mill. $) CardiologyCH12,0001,10090,000100 Ideas Detector Modules (IDM): Ideas Production of Camera Heads (CH)**: ** The markets for Scintimammografy and Animal are yet to be developed and therefore not included ModalityProductMarket (cm2) Annual Growth Sales price from Ideas ($/cm2) Annual market pot. 2002 (mill.$) SPECTIDM6,000,0005%25150 PETIDM** 2,150,000* 20%100215 * Will increased with systems width ** CTI 40% marketshare announces 69 PET orders in Q3 August 5th.03

7. 7 What do Ideas want to achieve ? Find an industry partner for the Prostate Probe Develop an Ideas Detector Module for PET

8. 8 How it works Compton-probe (scatter-sensor) Absorbtion Sensor #1 Absorbtion Sensor #2  - interactions Malignant tumor with agent- uptake

9. 9 Ongoing investments SPECT Ideas Detector Module for SPECT: Stand. Segemented Modules as an alternative to similar CZT Modules and PMT Known and available scintillator and detector technology New and unique version of ASIC Under developed jointly together with customer (50% co-ownership) Ideas bus. pot. for IDM SPECT = 6 mill. cm2 * 25$ = 150 mill.$

10. 10 Artistic illustration of the Prostate Probe

11. 11 Ongoing investments PET Ideas Detector Module for PET Standard Segemented Modules as an alternative to traditional PMT Known and available scintillator and detector technology New and unique version of ASIC and Module handling Depth Of Interaction Ideas started development based on market requirements and customer feedback Ideas bus. pot. for IDM PET = 2,15 mill. cm2 * 100$ = 215 mill.$ (high growth)

12. 12 Why an Integrated Project? EC FP6 (2003-2007) introduced two new tools: Networks of Excellence (NoE) and Integrated Projects (IP) IP’s meant for real delivery of products IP’s have higher funding than NoE, but strictly related to achievements New compared to FP5: large flexibility in project management, now entirely carried on inside the project (to the level of making bids for new partners)

13. 13 EuroMedIm and Emi-Care

14. 14 Objectives Proof of Concept, Early Demonstrators and Clinical Prototypes for: –Prostate Cancer –Breast Cancer –Brain Imaging –Whole-Body Multimodal Imaging Provide adequate set of radiotracers for each device, to be tested with the clinical prototypes Overall time scale: 5 years EuroMedIm

15. 15 22 Participants in the proposal Organisation of European Cancer Institutes (OECI) European Organisation for Nuclear Research (CERN) Karolinska Hospital/Institute (Karolinska) Vrije Universiteit Brussel (VUB) Centre Leon Berard (CLB-LCU) Deutsche Krebsforschungszentrum (DKFZ) Heidelberg (DKFZ) La Sapienza Università degli Studi di Roma (Uni Roma) Laboratório de Instrumentação e Física Experimental de Partículas (LIP) Consejo Superior de Investigaciones Científicas (CSIC) Ecole Polytechnique Fédérale de Lausanne (EPFL) Università di Pisa- Dipartimento di Fisica (Uni Pisa) Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano (ITM) Hospital Clínico San Carlos (SCH) Commissariat à l'énergie atomique (CEA) The University of Manchester (UoM) General Electric Medical Systems Israel LTD (GEMSI) SIEMENS AG (SIEMENS) Forschungszentrum Juelich GmbH (FZJ) VITAMIB Sarl (VITAMIB) Centre Nationale de la Recherche Scientifique (CNRS/IN2P3) Tagusparque, S.P.D. PCT de Lisboa, S. A (Taguspark ) Advanced Accelerator Applications AAA) EuroMedIm

16. 16 What went wrong Too ambigiouse, driven by physicists Too short time to understand what was required Users (doctors) and industry came to late into the project Meetings at CERN with 100 people from 7-8 different nationalities EuroMedIm

17. 17 What did we learn EU do have a business focus – think product Look for the Industry-partner – that’s your market The need for SME opens up possibilities Be careful how you commit yourself –Be sure you have control of your part –It must be a core part of your development strategy You must be strong enough to say no to limit your responsibilities EuroMedIm

18. 18 EMI-CARE European Molecular Imaging Consortium for Advanced Research (Integrated Project) - Integration of nanotechnologies

19. 19 Participants TypeCountry Philips Medical SystemsIndustryNL Amersham PLCIndustryUK NovartisIndutryCH Siemens Medical SolutionsIndustryDE Gene ControlSMECH IdeasSMEN Photonic MaterialSMEUK EMI-CARE

20. 20 What went wrong 2 weeks prior to closing: –Novartis and Amersham withdraw because of IP-rights The rules from EU were ready much too late ! EMI-CARE

21. 21 What has Ideas achieved ? Worked together with Philips for 3 months: –Explaining and marketing our technology –Made them think our way for future directions –Made their R&D want to continue with Ideas New EU STREP project defined together with Philips and Photonics (May 2004) CERN is asked by Brussel to apply for a ”Network Of Excellence”. Ideas is asked to follow EMI-CARE and EuroMedIm

22. 22 Why is it worth fighting for Networking with your most important customers and partners Industry and R&D are forced to incorporate SME –Your chance in a life time !! From promising technology to products supported by the industry NFR grant for application support is very helpful Joint projects with the giants have a company value